Physiological Effects of Anticholinergic Drugs

Anticholinergic drugs exert widespread effects throughout the body by blocking the action of acetylcholine (ACh) at muscarinic receptors, which are distributed in various organ systems. This blockade disrupts the parasympathetic nervous system's control over involuntary physiological functions, leading to diverse outcomes depending on the receptor subtype and the location involved. While therapeutic in many settings, anticholinergic effects can also cause a range of side effects, especially in cases of toxicity or overdose. Understanding the specific functions of each muscarinic receptor subtype in different organs is crucial for appreciating the full spectrum of anticholinergic drug effects.

Effects on the Central Nervous System

In the brain, all five muscarinic receptor subtypes (M1-M5) are distributed, with the M1 receptor being the most implicated in the anticholinergic reaction. When acetylcholine is blocked in the central nervous system (CNS), it can lead to symptoms such as delirium, cognitive impairment, dizziness, sedation, and confusion. This is because M1 receptors play a crucial role in modulating cognitive function, learning, and memory. The elderly are particularly susceptible to these CNS effects, as age-related changes can exacerbate the cognitive decline associated with anticholinergic use. In severe cases, anticholinergic toxicity in the CNS can cause hallucinations and psychosis due to overstimulation of the central nervous system.

Ocular Effects

In the eyes, M3 receptors predominate, although all muscarinic subtypes are present. Under normal conditions, acetylcholine stimulates the M3 receptors in the iris sphincter, causing pupillary constriction (miosis). When anticholinergic drugs block these receptors, it leads to pupillary dilation (mydriasis) and blurred vision due to impaired accommodation. This is particularly problematic during activities requiring sharp vision, such as reading or driving at night. Additionally, prolonged mydriasis can make the eyes more sensitive to light and may exacerbate conditions such as glaucoma, where increased intraocular pressure is a concern.

Effects on Glands

Anticholinergic drugs significantly affect exocrine gland function, particularly the salivary glands and sweat glands. M1 and M3 receptors in the salivary glands are responsible for stimulating saliva production. Blocking these receptors leads to dry mouth (xerostomia) and difficulty swallowing, which can increase the risk of dental problems and oral infections. In the sweat glands, the predominant receptor is M3, and under normal conditions, acetylcholine promotes sweating to help dissipate body heat. Anticholinergic blockade of M3 receptors results in reduced sweating (anhidrosis), which impairs the body’s ability to cool itself. This can lead to overheating and an increased risk of hyperthermia during physical activity or in hot environments.

Cardiovascular Effects

In the heart, M2 receptors are responsible for modulating heart rate and contractility by slowing pacemaker activity and reducing atrioventricular (AV) conduction. When anticholinergic drugs block M2 receptors, it results in a faster heart rate (sinus tachycardia) and increased cardiac output due to enhanced contractility. This effect can be useful in clinical settings where bradycardia (abnormally slow heart rate) is a concern, such as during surgery. However, in the context of anticholinergic toxicity, excessive tachycardia and palpitations may occur, which can be particularly dangerous for patients with pre-existing heart conditions like ischemic heart disease or heart failure.

Respiratory Effects

In the lungs, M1-M4 receptors play a role in regulating bronchial smooth muscle tone and secretion. While muscarinic antagonists like ipratropium are therapeutically used to cause bronchodilation in patients with conditions such as asthma and chronic obstructive pulmonary disease (COPD), anticholinergic effects on the respiratory system are not typically associated with the classic anticholinergic reaction. Instead, these drugs are specifically designed to inhibit bronchoconstriction, providing relief for respiratory pathologies. Anticholinergics used in this setting help reduce airway resistance and facilitate easier breathing by relaxing the bronchial smooth muscles.

Gastrointestinal Effects

The gastrointestinal (GI) system is heavily influenced by acetylcholine through M2 and M3 receptors, which are responsible for stimulating gastric motility and smooth muscle contraction. When anticholinergic drugs block these receptors, it leads to decreased peristalsis, resulting in gastric stasis, constipation, and in severe cases, paralytic ileus. These effects can be uncomfortable for patients and are particularly problematic in the elderly, who may already suffer from slowed gastrointestinal transit. Decreased gastric motility can also lead to issues such as bloating, nausea, and the exacerbation of gastroesophageal reflux disease (GERD).

Urinary Effects

In the bladder, M3 receptors are primarily responsible for detrusor muscle contraction, which facilitates bladder emptying. Anticholinergic drugs that block M3 receptors inhibit bladder contraction, leading to urinary retention. This is especially common in elderly males with benign prostatic hyperplasia (BPH), who may already have difficulty voiding. The inability to effectively empty the bladder increases the risk of urinary tract infections and can cause discomfort or even acute urinary retention, requiring catheterization. While M2 receptors are also present in the bladder, their exact role in bladder function remains less clear, though they may contribute to detrusor relaxation.

Effects on Skin and Vasculature

The effects of anticholinergic drugs on the skin are primarily mediated through M3 receptors. Although acetylcholine can influence vasodilation via muscarinic receptors in the vascular endothelium, the interaction is complex and involves multiple factors, including nitric oxide, norepinephrine, and prostaglandins. In cases of anticholinergic toxicity, vasodilation may occur in the skin, contributing to flushed skin and the body’s attempt to dissipate excess heat, particularly when sweating is impaired. The anticholinergic reaction can lead to a hot, dry, flushed appearance, commonly described in cases of severe anticholinergic poisoning.